Recs Updated for TB Screening, Treatment in Healthcare Workers
Guidelines include preplacement TB risk assessment, postexposure symptom evaluation and testing
Infectious Disease
FDA: Tattoo Inks Recalled Due to Bacterial Contamination
Symptoms of tattoo ink-associated infections include rashes, lesions in areas where ink has been applied
Prophylactic Antibiotic Cuts Infection Risk After Operative Vaginal Birth
Benefits seen following operative vaginal birth at 36 weeks of gestation or later.
CDC: US Measles Cases in 2019 Reach 839
Most on cruise ship under measles quarantine cleared to leave
T2Bacteria Panel Accurately IDs Bloodstream Infections
Mean time to species identification 3.61 to 7.70 hours, depending on number of samples tested.
Model Predicts Counties at Risk for Measles Outbreak
Counties identified as being at risk should be targeted for enhanced surveillance, vaccination
Kaposi Sarcoma Treatment Gets Breakthrough Therapy Designation
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Pomalyst (pomalidomide; Celgene) for the treatment of patients with Kaposi sarcoma.
CDC: Hepatitis A Virus Reports Increased in 2016 to 2018
Multiple infection outbreaks among those reporting drug use, homelessness account for most reports
CDC to Receive Large Donation of PrEP Medication to Help With HIV Prevention
Truvada is approved in combination with safer sex practices for HIV-1 PrEP to reduce the risk of sexually acquired HIV-1.
Gentamicin Evaluated as an Alternative Treatment Option for Gonorrhea
Gentamicin should generally not be considered a first-line option in the treatment of gonorrhea, however it may be useful in certain patients, according to the results of a recent non-inferiority trial.
